Bruker · 2 days ago
Scientist
Bothell, WA
Full-time
Onsite
Entry, Mid Level
$101K/yr - $156K/yrBruker is one of the world’s leading analytical instrumentation companies enabling scientists to make breakthrough discoveries. They are seeking a Computational Biologist II / Biostatistician II / Bioinformatics Scientist II to tackle research and development challenges, including training deep learning models and developing new statistical methods.
ChemicalLife ScienceManufacturingMedical
Responsibilities
Training deep learning models on both transcriptomic and protein imaging data
Developing new statistical and computational methods
Creating and contributing to open-source software tools
Collaborating with cross-functional teams of biologists, assay developers, and software engineers
Qualification
Required
PhD in Computational Biology, Biostatistics, Bioinformatics, Computer Science, or a related field (new graduates welcome)
Demonstrated expertise in neural network training as a major part of your research or applied work
Strong programming skills in Python and/or R
Preferred
Familiarity with single-cell or spatial omics data
Some expertise in cancer biology, neuroscience or cellular biology
Experience contributing to open-source projects
Benefits
401(k) with company match
Employee stock purchase plan
Medical and dental plans
Life insurance
Short-term and long-term disability insurance
Employee assistance program
Paid time off including vacation, sick time and holidays
Company
Bruker
Bruker is a manufacturer of analytical and medical instruments covering NMR, ESR, FT-IR, X-RAY spectroscopy.
Founded in 1960
5001-10000 employees
H1B Sponsorship
Bruker has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (1)
2023 (1)
2022 (2)
Funding
Current Stage
Public CompanyTotal Funding
$1.01BKey Investors
Thomas Weisel Partners
2025-09-03Post Ipo Equity· $582M
2024-05-29Post Ipo Equity· $403.74M
2019-12-12Post Ipo Debt
Leadership Team
Frank Laukien
Chief Executive Officer
Jason Faessler
Senior Vice President Finance
Recent News
2026-01-11
startupticker.ch
2026-01-11
Company data provided by crunchbase